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Preparation of Hydrophilic C60(OH)10/Cyclodextrin Nanoparticles and Their 
Application to Treatment of Diseases Induced by Oxidative Stresses 
Yoshitaka Umezaki 
 
Fullerenes, large spherical molecules composed of only carbon atoms, have been of 
great interest for practical applications that exploit their unique electronic 
properties and biological activities. The fullerene family, especially C60, has 
appealing photo-, electro-chemical and physical properties, which have been 
exploited in various medical fields. For example, it can function as a radical 
scavenger, an antioxidant and as a gene carrier or in drug delivery. Polyhydroxylated 
fullerenes (C60(OH)n), some of the simplest C60 derivatives, show antioxidant effect 
and are regarded as potential candidates for use in scavenging reactive oxygen 
species (ROS), which arise due to neuroprotective and cytoprotective effects by 
reducing oxidative stress. Although C60(OH)n are more soluble than unmodified C60, 
further enhancement in their solubility is necessary for a precise evaluation of their 
biological activities and for extensive biomedical applications. The objective of this 
study is to prepare stable hydrophilic C60(OH)10 nanoparticles using 2-
hydroxypropyl-?-cyclodextrin (HP-?-CyD) and to evaluate its biological activities of 
ROS scavenging ability. Furthermore, a protective effect against acetaminophen 
(APAP) overdose induced liver injury that is related to oxidative stress was examined. 
The results are summarized as follows. 
 
1) C60(OH)10 nanoparticles were produced by cogrinding ?-CyD, ?-CyD, ?-CyD and 
HP-?-CyD at 4 ˚C under reduced pressure. Among various CyDs, HP-?-CyD and 
?-CyD formed hydrophilic nanoparticles with C60(OH)10 in high yields. The 
solubility of C60(OH)10 increased to about 720 ?M and 690 ?M in the HP-?-CyD 
and ?-CyD nanoparticles, respectively. Particle sizes of hydrophilic C60(OH)10 
nanoparticles decreased with cogrinding time and increasing the CyD/C60(OH)10 
molar ratio (C60(OH)10/HP-?-CyD : 46.7?10.9 nm, C60(OH)10/?-CyD : 81.3?10.3 
nm, (C60(OH)10 : CyDs = 1:3)). The resulting C60(OH)10/CyDs nanoparticles were 




2) C60(OH)10/HP-?-CyD nanoparticles rapidly reacted with DPPH and ABTS 
radicals and scavenged O2•? and •OH in a concentration dependent manner, 
when compared with C60(OH)10 alone and C60(OH)10/?-CyD nanoparticles. The 
scavenging ability of C60(OH)10/HP-?-CyD nanoparticles was higher than that of 
C60(OH)10/?-CyD nanoparticles, which may be due to the difference in surface 
areas between the HP-?-CyD nanoparticles (46.7 nm) and the ?-CyD 
nanoparticles (81.3 nm), i.e. the surface area involved in the scavenging is larger 
in the former particles than in the latter particles. 
 
3) When C60(OH)10/HP-?-CyD nanoparticles were intraperitoneally or 
intravenously administered to mice with a liver injury induced by an overdose of 
APAP, the ALT and AST levels were markedly reduced to almost the same level 
as that of normal mice. To reveal the mechanism responsible for liver protection 
by C60(OH)10/HP-?-CyD nanoparticles, GSH level, CYP2E1 expression and 
peroxynitrite formation in the liver were assessed. C60(OH)10/HP-?-CyD 
nanoparticles had no effect on CYP2E1 expression and GSH depletion, but 
suppressed the generation of peroxynitrite in the liver. The findings indicated 
that the protective effect of C60(OH)10/HP-?-CyD nanoparticles was due to the 
suppression of oxidative stress in mitochondria, as the result of scavenging ROS 
such as O2•?, NO and peroxynitrite, which act as critical mediators in the liver 
injuries. 
 
Stable hydrophilic C60(OH)10 nanoparticles were prepared by grinding with HP-?-
CyD. C60(OH)10/HP-?-CyD nanoparticles were found to scavenge not only free 
radicals (DPPH and ABTS radicals) but also ROS (O2•? and •OH). By modifying the 
particles to acquire hydrophilic characteristics, they became more water soluble. In 
addition, the C60(OH)10/HP-?-CyD nanoparticles were found to show a protective 
effect against APAP induced liver injury and the hepatoprotective effect of the 
nanoparticles was due to their ability to scavenge ROS such as O2•? , NO and 
peroxynitrite. The developed C60(OH)10/HP-?-CyD nanoparticles have the potential 
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19) ????????????? C60(OH)n ????????????????
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Fig. 1. Chemical Structure of C60 (a) and C60(OH)n (b) 





? ? ? ? ? ? ? ? ? ?  
 
 




????24) ???CyD ?????? 2-?????????-?-CyD?HP-?-CyD?
???????????????????????????????????
?????????????????????25) 
???????????? C60 ??????????????HP-?-CyD ?
????C60 ?????????????????????????????
Fig. 2. Chemical Structure of CyDs Used in This Study 
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?Fig. 3??26) ?? C60/HP-?-CyD ????????????????????
???????????????????1O2???????????????
????O2????????????????????????????????









????? HP-?-CyD ?????C60 ?????? 10 ????? C60(OH)10 
?????????????????????????????? 
?????? 1 ??? C60(OH)10 ??? CyDs ?????????? 
C60(OH)10/CyDs ????????????????????????????
????????????????? 2 ??? C60(OH)10/CyDs ??????
???? in vitro ?????HP-?-CyD ???????? C60(OH)10/HP-?-
CyD ?????????????????????????? 3 ?????
Fig. 3. Proposed Structure of C60/HP-?-CyD Nanoparticles 
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?????? C60(OH)10/HP-?-CyD ??????????????????? 
????????????????????APAP ????????????
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? 1 ?? ??? C60(OH)10/CyDs ???????????? 
 
? 1 ?? ? 
 
C60(OH)n ? ??????????????? 10 ????????? 40 
???????????????????????????? 12 ?????
?????????????? 20 ???????????????????
????????28) ??????????????? 20 ?????????
??????????29-31) ????????????????????? 
C60(OH)n ???????????????????????? ? 10 ???




Fig. 4 ????? C60(OH)10 ?????????????????????
??????????????????????????????? 10 ??
Fig. 4. ? Atmospheric Pressure Chemical Ionization (APCI) Mass 
Spectrum of C60(OH)10 Used in This Study 
 - 7 - 
 
?????? 890 ? C60(OH)10 ?????50? ?????????????
????????? 8 ?? 12 ????? C60(OH) 10?2 ?????????
?????????????????????????????? C60(OH)10 ?




? 2 ?? CyDs ????????? C60(OH)10 ?????? 
 
??? C60(OH)10/CyDs ??????Fig. 5 ??????????????
???????????????? C60(OH)10 ??? CyDs ?????4 ? 
? 3 ??????????? 1?3?C60(OH)10?CyD????????????
???0.2 ?m ?????????????????? 
 
 





Fig. 5.? Automatic Magnetic Agitating Mortor (MNV-01, ASONE) 







Fig. 6 ? C60(OH)10 ??? CyDs ???????????? X ????
???????C60(OH)10 ? C60 ?????????? 10 ????????
????????????????????????????????????
???????????? CyDs ??? ?-CyD??-CyD ??? ?-CyD ???
????????????????????????????-CyD ? 2, 3, 6 ?
Fig. 6. ? Powder X-Ray Diffraction Patterns of C60(OH)10, CyDs and 
C60(OH)10/CyDs Powders Ground for 3h at 4?C under Reduced Pressure 
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???? 2-???????????????????? HP-?-CyD???? 
5.0????????????????????????? CyDs ? C60(OH)10 
?????????HP-?-CyD ?????HP-?-CyD ???????????
???????????HP-?-CyD ??????? C60(OH)10 ? 5 ????
??????? C60(OH)10 ? HP-?-CyD ????????????????
???????????? CyDs ????????? CyDs ????????







Fig. 7 ??C60(OH)10 ??? CyDs ???? 1?3 ? 3 ????????
????? C60(OH)10 ??? 1 mM ????????????0.2 ?m ???
????????????????C60(OH)10 ??????????????
??????????? C60(OH)10 ??? UV ?????????????? 
C60(OH)10 ?????????????????????????? 0.2 ?m ?
Fig. 7. ? Appearances of C60(OH)10 and C60(OH)10/CyDs Colloidal 
Solutions after Filtration through 0.2 μm Filter 
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????????????????????????? HP-?-CyD ??? ?-
CyD ???????????????????????????????? 
C60(OH)10 ????????????????????????????????










???? C60(OH)10 ??? 350 nm ??????????????? Fig. 
8 ??????? C60(OH)10 ????CyD ?????????????????
????? ?- ??? ?-CyD ???? HP-?-CyD ??? ?-CyD ?????
??????????? 1?3 HP-?-CyD ??? ?-CyD ??? C60(OH)10 ?
Fig. 8. ? Apparent Solubilities of C60(OH)10 Ground at Various Molar 
Ratios of C60(OH)10/CyDs  
Each point represents the mean ?S.E. of 3 experiments. *p < 0.05 compared with the 
?-CyD, #p < 0.05 compared with the ?-CyD. 
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??? 700 ?M ???????????????????????C60(OH)10 ?
?? 1 mM ?????? C60(OH)10/HP-?-CyD ????????????0.2 
?m ?????????????????????????????? 
C60(OH)10 ??1 mM??? 70? ?????????????????-CyD ?
??? ?-CyD ???????????? 1?4 ?C60(OH)10?CyD????? 
500 ?M ???????????????????????????????
???????????????????C60(OH)10 ????? HP-?-CyD ?
??? ?-CyD ????????????????????????????? 
 
 
? 3 ?? ??? C60(OH)10/CyDs ????????? 
 
? 1 ?? C60(OH)10/CyDs ??????????????????? 
 
C60(OH)10 ?????????????? HP-?-CyD ??? ?-CyD ???
????? C60(OH)10/CyDs ??????????????????????
????????????????Fig. 9 ???? CyD ????1?0.5?5?
??????? C60(OH)10/CyDs ????????????HP-?-CyD ???
?????????????? HP-?-CyD ?????????????????
????-CyD ????CyD ????????????? 2? ?11??17? ??
? 22? ??? ?-CyD ????????????????????????-CyD 
??????????C60(OH)10 ???????????????? ?-CyD ?
???????????? 





Fig. 9.? Powder X-Ray Diffraction Patterns of C60(OH)10/HP-β-CyD (a) and 
C60(OH)10/?-CyD (b) Powders Prepared at Various Molar Ratios of 
C60(OH)10 : CyDs 
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Fig. 10 ??????????????????????????????? 
C60(OH)10/CyDs ????????????????Dynamic Light Scattering 
Spectrometer, DLS???????????????????????????
????? CyDs ????????????HP-?-CyD ????? 1?3 ?? 
50 nm???-CyD ??? 80 nm ????????????????? 1?5 ?
????? HP-?-CyD ??? ?-CyD ?????????????????
???CyDs ??????????????????????????????
???????????????????????????????????
C60(OH)10/HP-?-CyD ??? C60(OH)10/?-CyD ?????????????? 







Fig. 10.? Effects of C60(OH)10/CyDs Molar Ratios on Particle Size (a) and 
Zeta Potential (b) 
Each point represents the mean ?S.E. of 3 experiments.  












Fig.12.? Effects of Grinding Time on Particle Size of C60(OH)10/HP-?-CyD 
Nanoparticles 
Each point represents the mean ?S.E. of 3 experiments. 
Fig. 11.? Particle Size Distribution of C60(OH)10/HP-?-CyD Nanoparticles 
(a) and C60(OH)10/?-CyD Nanoparticles (b) 
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???C60(OH)10 ????????? HP-?-CyD ????????????
?????Fig. 12 ???????????????????????????
???3 ???????? 50 nm ???????????????? 3 ??
??????????????????????????????????? 
C60(OH)10/HP-?-CyD ???????????????????????Fig. 









????????C60(OH)10 ? HP-?-CyD ? ?-CyD ?????????? 
100 nm ????????????????????????????????
CyD ??????? 1?3 ????? C60(OH)10 ?????????????
????????????????????????????????????
???????????  1?3???????  3 ?????????? 





Fig. 13.? TEM Image of C60(OH)10/HP-?-CyD Nanoparticles 
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? 2 ?? C60(OH)10/CyDs ?????????????? 
 
HP-?-CyD ??? ?-CyD ?????C60(OH)10 = 400 ?M????????
?????? DLS ????????????????????Fig. 14 ???
??????????????  28 ???????????????? 
?C60(OH)10/HP-?-CyD ?? 50 nm?C60(OH)10/?-CyD?? 80 nm??????









Fig. 14.? Changes in Particle Size of C60(OH)10/HP-?-CyD Nanoparticles 
and C60(OH)10/?-CyD Nanoparticles during Storage at 25?C  
Each point represents the mean ?S.E. of 3 experiments. 
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? 4 ?? ?? 
 
? C60(OH)10 ?  HP-?-CyD ???  ?-CyD ????????????? 
C60(OH)10 ??????????????????????-CyD ??? ?-CyD 
?? C60(OH)10 ??????????????????????????? 
C60(OH)10/HP-?-CyD ??????? C60(OH)10/?-CyD ??????????
???? 50 nm ?? 80 nm ????? 1 ???????????????
?????????? C60 ???????? 1.0 nm???????? ?-CyD 
??C60 ???? 2?1??-CyD?C60???????????????????
???32-33) ?????????? ?-CyD ??? ?-CyD ??C60 ??????
??????????????????Iohara ?????HP-?-CyD ??? ?-
CyD ??????? C60 ?????????????HP-?-CyD ? C60 ??
??????????????????????C60 ????????????
??????26) C60(OH)10 ????????? HP-?-CyD ??? ?-CyD ??
??????????????????????????????C60(OH)10 ?
?????? CyD ??????????????????????????
??????C60(OH)10 ??????????????? 1?1?C60(OH)10 ?
CyD????? ?41 mV ??????CyD ???????????????
???????????Fig. 10 (b)??????CyDs ????? C60(OH)10 ?
????????????????????????????????????
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? 5 ?? ?? 
 




1?C60(OH)10 ? HP-?-CyD ??? ?-CyD ?????4 ? ????????
???????? C60(OH)10 ?????????C60(OH)10 = 700 ?M????
???????????-CyD ???? ?-CyD ??????????????
??????????????????????????????? 
 
2?C60(OH)10 ????????? HP-?-CyD ??? ?-CyD ???????
??????????? CyDs ?????????????????? 1?3
?C60(OH)10 ?CyDs??3 ????????????????? 50 nm ???
? 80 nm ? C60(OH)10 ?????????????????????-CyD ?
??? HP-?-CyD ?????????? 
 
3?C60(OH)10/HP-?-CyD ??????? C60(OH)10/?-CyD ????????
???? ?40 mV ???????????????????????????
?????????C60(OH)10 ????????????????? 
 
4?C60(OH)10/HP-?-CyD ??????? C60(OH)10/?-CyD ????????
?????????????????????????????????????
28 ??????????????C60(OH)10/HP-?-CyD??  50 nm?
 - 19 - 
 
C60(OH)10/?-CyD?? 80 nm??????? 
 
????????C60(OH)10 ??HP-?-CyD ??? ?-CyD ????????
????????????????????????????????????
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? 2 ?? C60(OH)10/CyDs ??????????? 
 









? ?????????C60(OH)10 ?????????? HP-?-CyD ???? ?-
CyD ?????4 ??? 3 ???????????????????????
??????????????  C60(OH)10/HP-?-CyD ??????? 
C60(OH)10/?-CyD ???????????????????????????
?????C60(OH)10/HP-?-CyD ??????? C60(OH)10/?-CyD ????? 
in vitro ????????????????????? 2,2-Diphenyl-1-(2,4,6-
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? 2 ?? C60(OH)10/CyDs ???????????? 
 
? 1 ?? C60(OH)10/CyDs ????? DPPH ??????? 
 
Fig. 13 ???????? DPPH ???????????????????
? DPPH ????????????????????540 nm ???????
??????34) ??????????? C60(OH)10/CyDs ?????????
?????????????????1 ???????????????? 
C60(OH)10 ????????????????? 
? ? ?  ? ?  
 
 
Fig. 14 ???????C60(OH)10/HP-?-CyD ??????? C60(OH)10/?-
CyD ??????????? 540 nm ?????????DPPH ?????
???????????????????? C60(OH)10 ???? DPPH ??
???????????????????? C60(OH)10/CyDs ???????
???????????HP-?-CyD ??????? ?-CyD ?????????
?? DPPH ??????????????????????C60(OH)10 ?? 
250 ?M ???????????? HP-?-CyD ?????? 38???-CyD ?
????? 33? ????? 
Fig. 13. Reduction of DPPH Radical by Antioxidants 
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Each point represents the mean ± S.E. of 4 experiments. 
?
, p < 0.05 versus C60(OH)10 dispersion 
Fig. 14. DPPH Radical Scavenging Activities of C60(OH)10/HP-?-CyD 
Nanoparticles, C60(OH)10/?-CyD Nanoparticles and C60(OH)10 Dispersion 
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? 2 ?? C60(OH)10/CyDs ????? ABTS ??????? 
 
Fig. 15 ????????  ABTS ????????ABTS ????? 
DPPH ??????????????????????????? ABTS ?






Fig. 16 ???????C60(OH)10/HP-?-CyD ??????? C60(OH)10/?-
CyD ??????????????????? ABTS ??????????
????C60(OH)10 ?? 200 ?M?15 ??????????HP-?-CyD ???
?? 73???-CyD ????? 60? ????HP-?-CyD ??????? ?-
CyD ???????????????????????????C60(OH)10 ?
??? ABTS ????????????????????? 25? ?????
??HP-?-CyD ?????? ?-CyD ?????DPPH ??????? ABTS 
???????????????????data not shown??????????
C60(OH)10 ???????????????????????????????
?????????????????? HP-?-CyD ??????? ?-CyD ?
???????????????????? 
Fig. 15. Reduction of ABTS Radical 










? 3 ?? C60(OH)10/CyDs ????????? 
 
??????? DPPH ????? ABTS ??????????????
??????????????????C60(OH)10/CyDs ??????????
???????????????? •OH ??? O2•??NO ???????
???????? 
 
Fig. 16. ABTS Radical Scavenging Activities of C60(OH)10/HP-?-CyD 
Nanoparticles, C60(OH)10/??-CyD Nanoparticles and C60(OH)10 Dispersion 
Each point represents the mean ± S.E. of 4 experiments. 
†
, p < 0.05 versus 
C60(OH)10/?-CyD nanoparticles. 
 - 25 - 
 
? 1 ?? C60(OH)10/CyDs ????? •OH ??? 
 
•OH ?????Fenton ???H2O2 + Fe2+ ? •OH?????????
•OH ? ESR ?????????????????36) ESR ????????
??????????????????? ROS ?????????????
?????????????????????????? ESR ??????
??????????Fig. 17 ???????ESR ???????????? 
5,5-Dimethyl-1-pyrroline-N-oxide?DMPO?? Fenton ????????? 
•OH ? DMPO-OH ??????????????? DMPO-OH ????






Fig. 18?a????????DMPO-OH ????? ESR??????AN =1.49 
mT?AH =1.49 mT???????????????????????????
?????? ESR????????C60(OH)10/HP-?-CyD ?????????
???????????C60(OH)10/CyDs ?????????? •OH ????
Fig. 17. Fenton Reaction and Detection of •OH by ESR Spin-trapping 
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??DMPO-OH ??????????????Fig.18?b? ???????? 
Mn2+ ???????? DMPO-OH ????????????????? 
•OH ???????C60(OH)10 ????????? •OH ????????
C60(OH)10 ?? 25 ?M ?????????HP-?-CyD ????? 84???-CyD 
????? 67??C60(OH)10 ???? 21? ?????•OH ????? HP-













Fig. 18. ESR Spectra (a) of DMPO-OH Adduct in the Presence and 
Absence of C60(OH)10/HP-?-CyD Nanoparticles and •OH Scavenging 
Activities (b) of C60(OH)10 Dispersion, C60(OH)10/HP-?-CyD Nanoparticles 
and C60(OH)10/?-CyD Nanoparticles  
Each point represents the mean ± S.E. of 3 experiments. *p < 0.05 compared with the 
C60(OH)10/?-CyD nanoparticles. # p < 0.05 compared with the C60(OH)10 
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? 2 ?? C60(OH)10/HP-?-CyD ????? O2•? ??? 
 
O2•? ????????????????????????????????
?? O2•? ? ESR ????????????????????•OH ????
??? ESR ???????????? DMPO ????O2•? ???????





Fig. 20?a????????DMPO-OOH ????? ESR ???????
????? AN =1.43 mT?AH??=1.17 mT?AH? =0.125 mT ?????????
??????C60(OH)10/HP-?-CyD ??????????????????Fig. 
20?b???Mn2+ ???????? DMPO-OOH ?????????????
???? O2•? ???????O2•? ???? C60(OH)10/CyDs ???????
??????100 ?M ?????????HP-?-CyD ????? 47???-CyD 
????? 38??C60(OH)10 ???? 25??????HP-?-CyD ????? 
?-CyD ????? C60(OH)10 ???????? O2•? ???????????
Fig. 19. Detection of O2•? by ESR Spin-trapping 
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? 3 ?? C60(OH)10/HP-?-CyD ????? NO ??? 
 
Snezana ???C60(OH)24 ? in vitro ??? in vivo ?????NO ???
????????????????SNP??????? NO ????????
???????17) ?????????????? C60(OH)10/HP-?-CyD ???
?? NO ??????????????????????????? E ??
???????????????????????????????????
Fig. 20. ESR Spectra (a) of DMPO-OOH Adduct in the Presence and 
Absence of C60(OH)10/HP-?-CyD Nanoparticles and O2•?  Scavenging 
Activities (b) of C60(OH)10/HP-?-CyD Nanoparticles, C60(OH)10/?-CyD 
Nanoparticles and C60(OH)10  
Each point represents the mean ± S.E. of 3 experiments. *p < 0.05 compared with the 
C60(OH)10/?-CyD. # p < 0.05 compared with the C60(OH)10 
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?????????????????????NO ??SNP ?????Xenon 
light, 35 mW/cm2, 5 min??????????????? NO ?? Griess ?
????????Fig. 21 ???????C60(OH)10/HP-?-CyD ???????
???? NO ???????100 ?M ???????? 67? ????????
??????????????????????????? NO ??????












Fig. 21.? NO Scavenging Activities of C60(OH)10/HP-?-CyD Nanoparticles, 
Ascorbic Acid, Trolox and Edaravone 
Each point represents the mean ± S.E. of 3-4 experiments.  
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????????????? HeLa ???????????? A549 ???
????? C60(OH)10/HP-?-CyD ????????????????????
????Fig. 22 ????????????????? C60(OH)10 ?????? 
HP-?-CyD ??? HeLa ????? A549 ???????????????
???????????????????????C60(OH)10/HP-?-CyD ??














? 2 ?? HepG2 ????? HeLa ?????? C60(OH)10/HP-?-CyD ??
????????????? 
 
??????? HepG2 ????? HeLa ???????H2O2 ?????
?????????? C60(OH)10/HP-?-CyD ???????????????
Fig. 23 ??H2O2 ???????????????????? ROS ???? 
CellROX? Green ??????????????????????????? 
CellROX? Green ????? ROS ?????????????? ROS ??
????????HepG2 ????? HeLa ??? H2O2 ?????????
??????????????????????????????C60(OH)10/HP-
?-CyD ???????????????????H2O2 ??????????
Fig. 22.? Cell Cytotoxicity of C60(OH)10/HP-?-CyD on Hela Cells (a) and 
A549 Cells (b) 
Each point represents the mean ± S.E. of 4 experiments. 
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??????????????H2O2 ???????? Control ??????
?????????????????C60(OH)10/HP-?-CyD ????? H2O2 ?
???????????????????????????????????
Fig. 24 ? H2O2 ?????????????????????H2O2 ????
???HepG2 ????? HeLa ?????????? 50? ???????









? ?  
Fig. 23. Antioxidant Effects of C60(OH)10/HP-?-CyD Nanoparticles on 
HepG2 Cells (a) and HeLa Cells (b) against Oxidative Stress Induced by 
H2O2 




















Fig. 24. Protective Effects of C60(OH)10/HP-?-CyD on HepG2 Cells (a) and 
HeLa Cells (b) against Oxidative Stress Induced by H2O2 
Each point represents the mean ± S.E. of 3 experiments. 
? 
p < 0.05 compared with the 
H2O2. 
# 
p < 0.05 compared with the H2O2 + C60(OH)10 dispersion.
 *
 p < 0.05 compared 
with the H2O2 + HP-?-CyD. 
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? 5 ?? ?? 
 
C60(OH)10/CyDs ?????????????DPPH ?????ABTS ??
?????? ROS?•OH?O2•? ?NO???????????????Figs. 14?
16?18?20?????C60(OH)10/HP-?-CyD ????????????????
???C60(OH)10/?-CyD ??????????????? C60(OH)10 ????
???????????? 1 ??????C60(OH)10/HP-?-CyD ??????






C60(OH)10/HP-?-CyD ????? NO ?????????????????
???? ???????????????????????????????
???Fig. 21?????????????????????Fig. 25 ?????
??????????????????????????????? 37)???
?????????????????????????? 1?????Fig. 25 
(a)???????????????????????????????ArOH?
????????????????????? 2 ????????Fig.25 (b)??
??????? O-H ????????????????????? 1 ???
???????????????????????Kato ?? C60(OH)32 ? 
Fenton ???????????????????????????? 
C60(OH)32 ?????????????? C60-O? ???????? ESR ?
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??????C60(OH)10 ???????????????????? C60 ???
????????????????????????????????????
???????????????C60(OH)10 ????????????????
?????????????? pKa ??????????Table 1 ?????
??C60(OH)10 ???????? pH ?????pH 11 ??????????
????????C60(OH)10 ? pKa ? 11 ??????????????? 






Fig. 25.? Radical Scavenging Mechanism of Phenolic Antioxidants 








C60(OH)10/HP-?-CyD ???????????? H2O2 ?????????
????????????????Figs. 23?24??C60(OH)10/HP-?-CyD ??
??????????????H2O2 ???????????????????
? C60(OH)10 ? H2O2 ?????????????????????????
????????????????????Fig. 22 ???????C60(OH)10 
???????????????????????????????????






Table. 1.? Solubilities of C60(OH)10 in Various pH Solutions 
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? 6 ?? ?? 
 
???? C60(OH)10/HP-?-CyD ??????? C60(OH)10/?-CyD ????




1?C60(OH)10/CyDs ????????????DPPH ?????ABTS ???
???????????????????????????? C60(OH)10 ??







3?C60(OH)10/HP-?-CyD ????? HeLa ????? A549 ???????
??????????????C60(OH)10/HP-?-CyD ????? HepG2 ??
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? 3 ?? ?????????????????? C60(OH)10/HP-?-CyD ??
??????? 
 









?????????C60(OH)10 ? HP-?-CyD ?????????????? 





????????APAP ??????? C60(OH)10/HP-?-CyD ??????
????????????????????C60(OH)10/HP-?-CyD ????? 
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? 2 ?? APAP ????????????? C60(OH)10/HP-?-CyD ????
??????? 
 
? 1 ?? C60(OH)10/HP-?-CyD ????????????????????
? 
 
APAP ? ? ? ? ? ? ? ? ? ?  APAP 400 mg/kg ? ? ? ?
?C57BL/6NSeaWT?????????????????51) APAP ?? 30 ?
?? C60(OH)10/HP-?-CyD ???????????????????APAP ?
? 24 ??????????????????????????????ALT?
AST????????Fig. 26??????????C60(OH)10 ????????





Fig. 27 ??APAP ??? C60(OH)10/HP-?-CyD ????????????
????? ALT?AST ????????APAP 400 mg/kg ????????
? ALT ???? AST ??????? 13000 IU/L?? 7000 IU/L ????
?????????????????? C60(OH)10/HP-?-CyD ????? 100 
mg/kg ??? 200 mg/kg ???????????????????????
?????????????? NAC ? 200 mg/kg ????????????
Fig. 26.? Protocol for Treatment of APAP Induced Liver Injury?
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?????????????????? C60(OH)10 ?????200 mg/kg ??
?????? ALT?AST ??????????APAP ??????????
???????????HP-?-CyD ???????????????????








Fig. 28??APAP ????C60(OH)10/HP-?-CyD ????????????
?? ALT ??AST ????????APAP 400 mg/kg ??????????
? ALT ??? AST ???C60(OH)10/HP-?-CyD ????? 50 mg/kg ??
? 1.5 mg/kg ???????????????????????NAC ???
????????????? ALT ??AST ???????????????
C60(OH)10/HP-?-CyD ?????????????????????????
???????????????????? 
?C60(OH)10/HP-?-CyD Nanoparticles were administered intraperitoneally.?
Each point represents the mean ±S.E. of 3-10 experiments. 
#p< 0.05 compared with the APAP alone.?
Fig. 27.? Effects of C60(OH)10/HP-?-CyD Nanoparticles on ALT (a) and 
AST (b) Levels in APAP Induced Liver Injury 










? 2?? C60(OH)10/HP-?-CyD ???????????????????? 
 
Fig. 29 ??APAP 300 mg/kg ?????????????? 30 ??? 
C60(OH)10/HP-?-CyD ??????? NAC ???????????????
?????????APAP ??????? 48 ??????????????
?????C60(OH)10/HP-?-CyD ?????????? NAC ???? 72 ?
???? 75? ????????????????? C60(OH)10/HP-?-CyD ?
???? 50 mg/kg ?????????????? 100? ????????
C60(OH)10/HP-?-CyD ?????????????????????????
???????????? 
?C60(OH)10/HP-?-CyD Nanoparticles were administered intravenously.?
Each point represents the mean ±S.E. of 7-11 experiments. 
#p< 0.05 compared with the APAP alone.?
Fig. 28.? Effects of C60(OH)10/HP-?-CyD Nanoparticles on ALT (a) and 
AST (b) Levels in APAP Induced Liver Injury?








? 3?? APAP ???????????? 
 
APAP 400 mg/kg ?????????????? 30 ??? C60(OH)10/HP-
?-CyD ???? 200 mg/kg ??? NAC 200 mg/kg ?????????Fig. 
30 ?? APAP ?? 24 ???????????????????APAP ??
??????????????????????????????C60(OH)10/HP-
?-CyD ???????? NAC ??????????????????????
????????????????????????????????????
???????????C60(OH)10/HP-?-CyD ????? APAP ??????
????????????????????????? 
Fig. 29.? Effects of C60(OH)10/HP-?-CyD Nanoparticles on Survival Rate 
in APAP Induced Liver Injury?
 - 43 - 
 




? 3 ?? C60(OH)10/HP-?-CyD ????? APAP ??????? 
 




???????????? APAP ??????????APAP ????? 
GSH ?????NAPQI ?????????? NAPQI ??????????
?????????????????ATP ????????????????
??????APAP ?????????52,53) ????????? NAC ??GSH 
?????????? NAPQI ???????????54,55) ?????????
APAP ????????????????? 3 ???? ? CYP2E1 ???
Fig. 30.? Effects of C60(OH)10/HP-?-CyD Nanoparticles (200 mg/kg) or 
NAC (200 mg/kg) on Appearance of Liver Injury Induced by Over Dose of 
APAP (400 mg/kg)  
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? 1 ?? C60(OH)10/HP-?-CyD ????? CYP2E1 ??????? GSH 
???????? 
 
Fig. 32 ??C60(OH)10/HP-?-CyD ??????? APAP ????????
???? CYP2E1 ??????????????????????????
?????APAP ??????????C60(OH)10/HP-?-CyD ???????
?? CYP2E1 ??????????????????C60(OH)10/HP-?-CyD ?
???????? GSH ?????????????????? (Fig. 33??
APAP ??????????? GSH ???????C60(OH)10/HP-?-CyD ?
?????????????????????????????????
C60(OH)10/HP-?-CyD ????? APAP ??????????CYP2E1 ??
? NAPQI ?????Fig. 31 ??? ??? GSH ??? NAPQI ????
?Fig. 31 ?????????????????????56) 
Fig. 31.? Pathogenesis of APAP Induced Liver Injury?
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Fig. 32.? Effects of C60(OH)10/HP-?-CyD Nanoparticles (200 mg/kg) on 
CYP2E1 Level Induced by APAP Over Dose (400 mg/kg) ?
Each point represents the mean ±S.E. of 3-4 experiments. ?
Fig. 33.? Effects of C60(OH)10/HP-?-CyD Nanoparticles (200 mg/kg) on 
Hepatic GSH Depletion Induced by APAP Over Dose (400 mg/kg)?
Each point represents the mean ±S.E. of 3-4 experiments. ?
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??C60(OH)10/HP-?-CyD ????? ONOO? ???? in vitro ??????
ONOO? ?????C60(OH)10/HP-?-CyD ????????????????
??ONOO? ????????????????? 123 ??????????
???????????????Fig. 34 ???????ONOO?  ?? 





?????? 17? ?????????C60(OH)10/HP-?-CyD ???????
??? 3? ?????????? NAC ????2????????????
???????????????????? ONOO? ? C60(OH)10/HP-?-CyD 
???????????????????????C60(OH)10/HP-?-CyD ???
???ONOO? ????????????????? APAP ????????
?????????? 
 
? ? ? ? ? ? ? ?  
 
 Each point represents the mean ± S.E. of 4 experiments. ?
Fig. 34. Perxoynitirite Scavenging Activity of C60(OH)10/HP-?-CyD 
Nanoparticles?








? 4?? ?? 
 
APAP ????????????? C60(OH)10/HP-?-CyD ???????
????????????????????? ALT ???? AST ????
???????????Figs. 27?28?????C60(OH)10 ??????????
???????????????? in vitro ?????????????
C60(OH)10/HP-?-CyD ?????????????????????????
????? in vivo ??????????????????????????
?????????????????APAP ???????????????
??????????????????????????ONOO? ??? 
Fig. 35. ? Immunohistochemical Staining of Liver Sections for 
Nitrotyrosine Protein Adducts after Treated with APAP alone, APAP+ 
C60(OH)10/HP-?-CyD Nanoparticles or APAP+NAC (a) and Nitrotyrosine 
Positive Rate in liver Sections (b)?
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C60(OH)10/HP-?-CyD ??????????????????Fig. 35??ONOO
? ? APAP ??????????????????????????????
??? NO ? O2•? ??????????????????????????
57) ??????????????????????? C60(OH)10/HP-?-CyD 
????????????????????????? in vitro ???? 
ONOO? ???????Fig. 34???????C60(OH)10/HP-?-CyD ????
? ONOO? ?????10 ?M?????????????????????? 









?? NAC ????????? CYP2E1 ????? NAPQI ?????? 
GSH ??? NAPQI ???????? C60(OH)10/HP-?-CyD ??????
????????????????????C60(OH)10/HP-?-CyD ??????
APAP ??????? ONOO? ????????????????????
??????????????????????????????????? 
NAC ?????????????????? APAP ???????????
?????? 
 











Fig. 36.? Proposed Mechanism for Protective Effect of C60(OH)10/HP-
?-CyD Nanoparticles against APAP Induced Hepatotoxicity?
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? 5 ?? ?? 
 




1?APAP ?????????? C60(OH)10/HP-?-CyD ??????????
??????????ALT ???? AST ?????????????????
????????????????????????????????
C60(OH)10/HP-?-CyD ????? APAP ????????????????
??????????????? 
 
2????????????????? NAPQI ??????? CYP2E1 ??
??  NAPQI ?????????  GSH ????????????
C60(OH)10/HP-?-CyD ????????? CYP2E1 ?????? GSH ??
????????????????????APAP ??????????
CYP2E1 ??? NAPQI ?????? GSH ??? NAPQI ??????
? C60(OH)10/HP-?-CyD ??????????????????? 
 




?-CyD ?????????????? ONOO? ?????????????




































??????????? HP-?-CyD ?????C60 ?????? 10 ????
? C60(OH)10 ?????????????????????????????? 
??????????????????? 
 
1?C60(OH)10 ? HP-?-CyD ??? ?-CyD ?????4 ? ?????????
?????????????? CyDs ??????????????????
?? 1?3?C60(OH)10 ?CyDs??3 ????????????????? 50 
nm ???? 80 nm ? C60(OH)10 ???????????????????? 
 





???????C60(OH)10/HP-?-CyD ??????? C60(OH)10/?-CyD ???
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?????????????????28 ???????????? 50 nm?? 
80 nm?????????? 
 
4?C60(OH)10/CyDs ????????????DPPH ?????ABTS ???
???????????????????????????? C60(OH)10 ??
??????????? ?????????? C60(OH)10/HP-?-CyD ???
?? C60(OH)10/?-CyD ????????????????? 
 




6?C60(OH)10/HP-?-CyD ????? HeLa ????? A549 ???????
??????????? C60(OH)10/HP-?-CyD ????? HepG2 ????? 
HeLa ?????? H2O2 ???????????????????????
??????? 
 
7?APAP ?????????? C60(OH)10/HP-?-CyD ??????????
??????????ALT ???? AST ?????????????????
????????????????????????????????????
?? C60(OH)10/HP-?-CyD ????? APAP ??????????????
????????????????? 
 
8????????????????? NAPQI ??????? CYP2E1 ??
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??  NAPQI ?????????  GSH ????????????
C60(OH)10/HP-?-CyD ????????? CYP2E1 ?????? GSH ??
????????? APAP ??????????CYP2E1 ??? NAPQI ?
????? GSH ??? NAPQI ??????? C60(OH)10/HP-?-CyD ??
?????????????????? 
 
9?In vitro ???????C60(OH)10/HP-?-CyD ????? ONOO? ????
?????????APAP ???????????????????????
????????????????C60(OH)10/HP-?-CyD ?????????
???  APAP ???????????????????????? 
C60(OH)10/HP-?-CyD ?????????????? ONOO? ???????
???????????APAP ????????????????? 
 
? ????? C60(OH)n ???????????????????DMSO ? 
DMF ????????????????????????????????
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????????????????????????????????????
??????C60(OH)10/HP-?-CyD ????????????????? APAP 
???????????????????????????????????






























????????? ??????? ????? ??? ????? ?? ????
?? ??? ????????????????? 
 
APAP ???????????????????????????????
???????????? ?????????? ?? ??? ????? ???
????? ??? ??????????????? 
 
??????????????????????????????????
????? ??? ??? ????? ?? ??????????????? 
 





??? 28? ?? 3? ? 
 






C60(OH)10? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  ?????????? 
?-CyD? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?????? 
?-CyD? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?????? 
?-CyD? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?????? 
NaOH? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ??????? 
DPPH? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?????? 
????????????? ? ? ? ? ? ? ? ? ? ? ? ?????? 
ABTS????????? ? ? ? ? ? ? ? ? ? ? ? ? ?????? 
DMPO? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ??????? 
H2O2? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?????? 
FeSO4? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  ?????? 
?????? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? GIBCO 
?????????? ? ? ? ? ? ? ? ? ? ? ? ? ? ? GIBCO 
?????????? ? ? ? ? ? ? ? ? ? ? ? ? ? ? GIBCO 
???????? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? SIGMA-ALDRICH 
???????????? ? ? ? ? ? ? ? ? ? ? ? ? Roche 
SNP? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? SIGMA-ALDRICH 
???????? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ??????? 
??????? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?????? 
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?????? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ????????? 
PrestoBlue? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? invitrogen 
CellROX Green? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? invitrogen 
APAP? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  ??????? 
NAC? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?????? 
????????? 123? ? ? ? ? ? ? ? ? ? ? ? ?  Cayman Chemial 
???????????? ? ? ? ? ? ? ? ? ? ? ? ? ??????? 
 
????????????????????????????????? Q
???? Q???????????????????????? 18.2 M??





???? ? ? ? ? ? ? ? ? ? ? ? ????? ? ? ? ? ? ?? 
 
????? ? ? ? ? ? ? ? ? ? ? AND? ? ? ? ? ? ? ? GR-200 
????????????? ? ? ????? ? ? ? ? ? MNV-01 
??????? ? ? ? ? ? ? ? ? ????? ? ? ? ? ? UT-105HS 
?????? ? ? ? ? ? ? ? ? ? ??? ? ? ? ? ? ? ? U-2800 
???????? ? ? ? ? ? ? ? EYELA? ? ? ? ? ?  SB-350 
???? ? ? ? ? ? ? ? ? ? ? ? ???? ? ? ? ? ? ? KA-1000 
????????? ? ? ? ? ? ? ???????? ? ? DLS-8000HL 
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???????? ? ? ? ? ? ? ? Sysmex? ? ? ? ? ?  Nano zs 
????????? ? ? ? ? ? ? Philips? ? ? ? ? ? ? TECNAI F20S-TWIN 
?? X ?????? ? ? ? ? ?  ???? ? ? ? ? ? ? RINT Ultima+ 
X-Band ?????????? ? ????? ? ? ? ? ? JES-FA100 
???????? ? ? ? ? ? ? ? ??? ? ? ? ? ? ? ? CCV-1300E 
CO2????????? ? ? ? ? ASTEC? ? ? ? ? ?  APC-30D 
???? ? ? ? ? ? ? ? ? ? ? ? ?????? ? ? ? ? CKX31 
???? ? ? ? ? ? ? ? ? ? ? ? ??? ? ? ? ? ? ? ? himac CT4D 
????????????? ? ? CORONA? ? ? ? ?  MTP-800 
 
3.? C60(OH)10/CyDs ??????? 
C60(OH)10 ? CyDs???? 1?3?C60(OH)10?CyD???????????
?????????????????????????????4 ? ? 3 ??
??????????????? 5.0 mL ?? C60(OH)10 ?? 1 mM ???
???????5 ????????????????????????? 0.2 ?m 
?????????????? C60(OH)10/CyDs ?????????? 
 
4.? ????? 
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5.? ??? C60(OH)10 ??? 
? C60(OH)10/CyDs ??????? 1??w/v?NaOH ???? 10 ?????




TEM ??? JEOL ?? JEM-1400Plus ????????? 100 kV ??





7.? ?? X ????? 
? ?? X ??????????? RINT Ultima+ ??? X ????????
??????????????????????????X ?? Cu-K??
?1.542 ???????40 kV?????40 mA??????5?/min??????
5~30???????1?-1?-0.15 mm? 
 
8.? C60(OH)10 ?????? 
? C60(OH)10 5.0 mg ???? 5.0 mL ??????1 ???????????
???????????? 
 
9.? DPPH ?????????? 
? DPPH 4.9 mg ? 50 mL ????????????????? 2?1?DPPH?
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????????????????? DPPH ?????????? 4?1 ??
??????20 ??????????????????????540 nm???
???DPPH ????????????????????? 
Radical Scavenging Activity (%) = 100?(Absorbance with Samples/Absorbance without 
Samples) ×100 
 
10.? ABTS ?????????? 
? ???????????? 9.94 mg ???? 15 mL ?????2.45 mM??
????? ABTS ????????? 16.44 mg ?????????????
????????ABTS ??????? PBS?pH=7.4??????7.5?92.5
?ABTS ???PBS????????? 9?1 ???????????????734 
nm????ABTS ????????????????????? 
Radical Scavenging Activity (%) = 100?(Absorbance with Samples/Absorbance without 
Samples) ×100 
 
11.? ESR ?? 
? ????????  X-Band ?????????  JES-FA100 ESR 
spectrometer ?????ESR ?????????????????????
??? 
Microwave frequency?9416.9 MHz?Microwave power?8.0 mW?Field 
modulation?0.1 mT at 100 kHz?Sweep time?2 min? 
 
11-1.? ???????????•OH????????ESR ????????? 
? 5,5-Dimethyl-1-pyrroline-N-oxide?DMPO???????????????
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????????? 100 ?L ? H2O2?4.4 mM?40 μL?DMPO 20 μL?FeSO4 
???2 μM?40 μL ????????????????????????? •OH 
???????FeSO4 ??? 2 ??? ESR ???????•OH ?????
??????????? 






????????? 100 ?L ???????????0.67 mM?60 μL?DMPO 
20 μL?????????????0.8 Unit/mL?20 μL ??????????
???????????????????? 1 ??? ESR ???????O2•
? ?????????????? 
 
12.? NO ?????? 
SNP?1 mM??????????SNP ?? 40 μL ??????? 40 μL
?????????Xenon light, 35 mW/cm2, 5 min????????? NO ?
?????????? NO ???????????? Griess Reagent Kit ?
????????NO ????????????? 100? ????????
??????? 
 
13.? HeLa ????? 
? ??????????????????? HeLa ?? 8 x 105?? 10??v/v?
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FCS ?? MEM ???????? 1 × 105U/L?????????? 0.1g/L?
10 mL ?????????????????100 mm???????37 ??5? 
CO2 ??????????????????????????????-EDTA 
???????????????700 rpm ? 5 ??????????????
??????????? 10??v/v?FCS ?? MEM ??? 1 × 105?/mL?
???????? 
 
14.? A549 ????? 
? ????????????????? A549 ?? 8 x 105 ?? 10? ?v/v?
FCS ?? DMEM ???????? 1 × 105U/L?????????? 0.1 g/L?
10 mL ?????????????????100 mm???????37 ??
5? CO2 ??????????????????????????????-
EDTA ???????????????700 rpm ? 5 ??????????
??????????????? 10??v/v?FCS ?? MEM ??? 1 × 105 
?/mL ????????? 
 
15.? HepG2 ????? 
? ??????????????? HepG2 ?? 8 × 105 ?? 10??v/v?FCS 
?? RPMI ???????? 1 × 105 U/L?????????? 0.1 g/L?10 
mL ?????????????????100 mm???????37 ??5? CO2 
??????????????????????????????-EDTA ??
?????????????700 rpm ? 5 ????????????????
????????? 10??v/v?FCS ?? RPMI ??? 1 × 105 ?/mL ??
??????? 
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16.? ?????? 
A549 ????? HeLa ??? 96-well culture plate ? 2 × 104?/well ?
?????????10??v/v?FCS ?????100 ?L?? 24 ???????
????????????20 ?L??????24 ??????PBS ???? 2 
?????PrestoBlue ?? 10 ?L ????????15?20????????
????????Excitation:535 nm?Emission:615 nm??????????
????????? 100? ?????????????????? 
 
17.? ???????????? 
? HeLa ????? HepG2 ??? 6-well culture plate ? 2 × 104 ?/well 
??????????10??v/v?FCS ?????2.0 mL??? 70? ???
????????????????????? 200 ??L ??? 24 ??????
PBS ???? 1 ??????????CellROX Green?5 μM????? 2 mL 
?????? 30 ????????????PBS ???? 3 ??????? 2 
mL?H2O2 0.4 mL?????3 ????????????PBS ???? 1 ?
????????????????????????????????????




HeLa ????? HepG2 ??? 96-well culture plate ? 2 × 104 ?/well 
??????????10??v/v?FCS ?????100 ?L?? 24 ?????
?????????20 μL??????24 ??????PBS ???? 2 ??
????? 100 μL ????H2O2 ? 750 μM?20 μL??????????1 
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?????????? PBS ? 1 ??????? 100 μL ????24 ???
???PrestoBlue ?????? 10 μL ?????????Excitation:535 nm?
Emission:615 nm?????????????? 
 
19.? APAP ??????????????????????? 
? APAP ? ? ? ? ? ? ? ? ? ?  APAP 400 mg/kg ? ? ? ?
?C57BL/6NSeaWT??????????????????APAP ???? 30 




20.? APAP ??????????????? 
? ????C57BL/6NSeaWT?? 24 ?????????APAP 300 mg/kg ?
????????????? 30 ??? C60(OH)10/HP-?-CyD ??????? 
NAC ?????????????????????????? 
 
21.? CYP2E1 ?? 
? ??? CYP2E1 ??? Western blot ??????????????? 
10?  ?????????????  SDS-PAGE ??????????? 
PVDF ???????5? ???????????????????????
? 3 ??????????Anti-CYP2E1 antibodies???????????? 
5? ????????????????? 4 ??????????? 3 ? 
Tween-20 ??  TBS ??????????HRP-conjugated secondary 
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antibodies????????ECL Western blotting analysis system?Amersham?
?????????????????? 
 
22.? GSH ???? 
? ?????????????? 5? ?????????????????
4 ?? 1000 g ?  10 ??????????????  GSH ??? 




? ????????? 4 ????????????????????????
Histofine® Simple Stain MAX PO?Nichirei Biosciences, Tokyo, Japan???
??????????????????3,3-diaminobenzidine ???????
Mayer's hematoxylin ?????????????????????




? ????????? 123 ???0.1 mM?50 μL ? C60(OH)10/HP-?-CyD ?
??? 50 μL ? 96-well plate ??????5 ??????????????
????????????0.28 mM?50 μL ???????????5 ???
?????Excitation:485 nm?Emission:535 nm???? 
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